News Story: Full Text
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

 

FDA Grants Genentech’s Avastin Full Approval for Most Aggressive Form of Brain Cancer

Al's Comment:

 This is great news.  I was worried that they would remove the approval based on the study mentioned.  The study showed "no significant increase in overall survival".   That study did not take into account how Avastin is used in the real world.  In the real world it is used in combination with many other things and is a very useful drug.  Our virtual trial is tracking the combinations.  One that looks exceptionally good (although only 4 patients used the combination) is Avastin plus Optune.  2 of the 4 patients died, but they survived an average of 30 months. The other 2 are alive - one for 22 months so far and the other an amazing over 8 years.


Posted on: 12/06/2017

FDA Grants Genentech’s Avastin Full Approval for Most Aggressive Form of Brain Cancer

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites



Musella Foundation For Brain Tumor Research & Information, Inc